Toggle light / dark theme

While many high-school sophomores are busy partying and socializing, Jack Andraka developed a test for pancreatic cancer that is the first test that detects the disease and tumors before they get out of hand.

And with pancreatic cancer having the lowest survival rate of any cancer, he truly accomplished something amazing with his work.

Pancreatic cancer shows no symptoms in the early stages and affects more than 8,000 people each year in the Uk and 45,000 in the U.S. Due to poor testing procedures in the past, by the time the cancer is detected, 4 out of 5 people are inoperable.

Ironically #AI has been proven to develop racial and gender bias. Gee, I wonder why?

For the second year in a row, more than a dozen AI researchers from African countries have been denied visas to a major AI conference in Canada.


Canada’s decision to refuse visas to African AI researchers seems ham-fisted, given that the country’s tech industry has been the beneficiary, in recent years, of America’s move toward isolationism. In 2017, Trudeau launched a visa program designed to attract high-tech workers—including those who found themselves unable to get into the US—by streamlining Canada’s visa-approval process. The recent decision to block access to NeurIPS for a diverse pool of talent appears to be a step in the opposite direction.

“It seems crazy,” says Joshua Gans, a professor at Toronto University’s Rotman School of Business who studies the impact of AI on innovation and economic growth. “What is the worst that happens? The scientists come here, stay here, and develop their AI here rather than in Africa?”\

Mathieu Genest, a press spokesperson for Citizenship and Immigration Canada, sent a statement that says the rules outlined by Canada’s Immigration and Refugee Protection Act (IRPA) apply “to everyone, regardless of nationality.” The statement adds that the department did receive the names of NeurIPS attendees who would apply for visas, which were shared with visa officers. And it says people can reapply, but should only do so if they have addressed the reasons their application was refused.

Questionable startups are claiming to be able to determine how smart a frozen IVF embryo will become if carried to term, and parents are taking the bait.

Genomic Prediction, the most prominent of these companies, offers tests to scan embryos for genetic diseases and other conditions — as well as genetic indicators that a future child will be in the bottom two percent of intelligence.

And MIT Technology Review reports that Genomic Prediction co-founder Stephen Hsu often uses media appearances to discuss future plans for a general intelligence test — something that, with current tech, is extremely unlikely to actually work.

If Goldman Sachs’ new tool launches through Marcus, a human-digital hybrid approach would be a wise choice.


Goldman Sachs created a market-ready robo advisor and is mulling how to launch it, Financial Planning reports. The automated platform will represent Goldman’s digital entry into the smaller investor market, per Rachel Schnoll — who recently became the head of Goldman’s FinLife CX RIA platform — as cited by Financial Planning. The new robo advisor may be built in part on algorithms that Goldman acquired from financial life management firm United Capital, when it acquired the company for $750 million in May.

The new robo advisor could be introduced to the market via Goldman’s Marcus segment — here’s why it would be a good match. Goldman could extend a portion of the personal touch it brings to its Private Wealth Management clients to Marcus clients by offering them financial advice via the new robo advisor.

This could help elevate the bank’s play to target more retail banking customers, and could make up for the fact that the high interest rate Marcus boasts slipped from 2.25% to 1.9% since July. But Marcus isn’t the only potential route to market: Goldman is also considering launching its robo tech to financial advisors on the United Capital platform, per Schnoll.

For a long time it’s been said “fusion is the energy of the future. And always will be”. But now, with an influx of private investment, fusion startups are in the race for the holy grail of energy — limitless, clean power. A company based in Oxford, U.K. believes they’re close.

#BloombergGiantLeap #Science #Technology

——-
Like this video? Subscribe to Bloomberg on YouTube: https://www.youtube.com/Bloomberg?sub_confirmation=1

Bloomberg is the First Word in business news, delivering breaking news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on…
Twitter: https://twitter.com/business
Facebook: /redirect?redir_token=sMVnUVHkuLGdg_BtCeREE1L095R8MTU3MzM3MDUzM0AxNTczMjg0MTMz&q=https%3A%2F%2Fwww.facebook.com%2Fbloombergbusiness&event=video_description&v=l50ZUdGeRlI

Instagram: /redirect?redir_token=sMVnUVHkuLGdg_BtCeREE1L095R8MTU3MzM3MDUzM0AxNTczMjg0MTMz&q=https%3A%2F%2Fwww.instagram.com%2Fbloombergbusiness%2F&event=video_description&v=l50ZUdGeRlI
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness
Instagram: https://www.instagram.com/bloombergbusiness/